AI Portfolio Summary
In 2024 Q4, Alerce Investment Management, L.P. maintained a portfolio of 5 distinct positions. The fund also reduced its exposure to VERONA PHARMA PLC by 57.3%.
Total Positions
5
Quarter
2024 Q4
Top Holding
ANNX (66.9%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-5 of 5
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ANNX
ANNEXON INC
|
Healthcare | 66.89% | 70.35% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
7,406,024 | $37,992,903 | 2020 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
AKBA
AKEBIA THERAPEU...
|
Healthcare | 19.23% | 12.17% |
#2
Prev: #2
|
6.5 | no change | no change |
P
S
|
5,747,906 | $10,921,021 | 2020 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
VRNA
VERONA PHARMA P...
|
Unknown | 7.19% | 9.50% |
#3
Prev: #3
|
3.9 | -117,880 | -57.3% |
P
S
|
88,000 | $4,086,720 | 2024 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
AMWL
AMERICAN WELL C...
|
Healthcare | 6.69% | 7.97% |
#4
Prev: #4
|
4.2 | no change | no change |
P
S
|
523,785 | $3,797,441 | 2024 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
WHWK
AADI BIOSCIENCE...
|
Healthcare | 0.00% | 0.00% |
#5
Prev: #5
|
1.5 | no change | no change |
P
S
|
659 | $2,079 | 2021 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) |
Showing 1-5 of 5 holdings